---
title: "“减肥神药”司美格鲁肽再登《新英格兰医学杂志》，口服版，显著降低心脏病发作和中风风险"
date: 2025-04-02T08:03:10Z
draft: ["false"]
tags: [
  "fetched",
  "生物世界"
]
categories: ["Duty"]
---
“减肥神药”司美格鲁肽再登《新英格兰医学杂志》，口服版，显著降低心脏病发作和中风风险 by 生物世界
------
<div><section data-pm-slice="0 0 []"><span mpa-font-style="m8zm82j61n40" data-mpa-action-id="m8slugegoe8" data-pm-slice="0 0 []"><section><font><section><font data-pm-slice='3 4 ["para",{"tagName":"section","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"mpa-font-style":"m8wjiebgs8v","data-mpa-action-id":"m8slugegoe8","data-pm-slice":"0 0 []","style":"font-family: \"mp-quote\", -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"para",{"tagName":"section","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"font","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"},"para",{"tagName":"section","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><section><a href="https://mp.weixin.qq.com/s?__biz=MzIzOTM4NDcyNw==&amp;mid=2247537249&amp;idx=3&amp;sn=513e839f9d48c7c41a5184ce45b71d32&amp;nwr_flag=1&amp;scene=21#wechat_redirect" imgurl="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlRNpTicHD8iagW8jsMl4BMZerHV0TrJXoichms5umCyLOWnialsMhTfdPcm0xEHDj3iaF6wVnNhSeq5oQ/640?wx_fmt=png&amp;from=appmsg" linktype="image" tab="innerlink" data-itemshowtype="0" target="_blank" data-linktype="1"><span><img data-backh="239" data-backw="562" data-imgfileid="100291912" data-ratio="0.4255555555555556" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlRNpTicHD8iagW8jsMl4BMZerHV0TrJXoichms5umCyLOWnialsMhTfdPcm0xEHDj3iaF6wVnNhSeq5oQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="900" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlRNpTicHD8iagW8jsMl4BMZerHV0TrJXoichms5umCyLOWnialsMhTfdPcm0xEHDj3iaF6wVnNhSeq5oQ/640?wx_fmt=png&amp;from=appmsg"></span></a></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJlV2jS7njo2yHWKXEuoVJgqj6Ty7PyFickrkUtvlHflZpy6pPlSegh0ebfiaZ8OITW9oeryhfkh7BYw/640?wx_fmt=jpeg" data-ratio="0.049074074074074076" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="28" data-imgfileid="100285703" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJlV2jS7njo2yHWKXEuoVJgqj6Ty7PyFickrkUtvlHflZpy6pPlSegh0ebfiaZ8OITW9oeryhfkh7BYw/640?wx_fmt=jpeg"></section><p><span><span leaf=""><span textstyle="">撰文丨王聪</span></span></span></p><p><span><span leaf=""><span textstyle="">编辑丨王多鱼</span></span></span></p><p><span><span leaf=""><span textstyle="">排版丨水成文</span></span></span></p><p><span><span leaf=""><br></span></span></p></font></section></font></section></span></section><section data-pm-slice="0 0 []"><strong mpa-font-style="m8zm82j64bn"><span leaf=""><span textstyle="">司美格鲁肽</span></span></strong><span leaf="" mpa-font-style="m8zm82j619mj"><span textstyle="">（Semaglutide）</span></span><span leaf="" mpa-font-style="m8zm82j6yor"><span textstyle="">是</span></span><strong mpa-font-style="m8zm82j6rfv"><span leaf=""><span textstyle="">诺和诺德</span></span></strong><span leaf="" mpa-font-style="m8zm82j61ra"><span textstyle="">公司开发的一款降糖药物，用于治疗 2 型糖尿病，2021 年 6 月，美国 </span></span><span leaf="" mpa-font-style="m8zm82j62xy"><span textstyle="">FDA 批准了司美格鲁肽作为</span></span><strong mpa-font-style="m8zm82j6d01"><span leaf=""><span textstyle="">减肥药</span></span></strong><span leaf="" mpa-font-style="m8zm82j61p78"><span textstyle="">上市</span></span><span leaf="" mpa-font-style="m8zm82j6uef"><span textstyle="">（商品名为Wegovy）</span></span><span leaf="" mpa-font-style="m8zm82j61op6"><span textstyle="">。该药物是一种胰高血糖素样肽-1</span></span><span leaf="" mpa-font-style="m8zm82j61elx"><span textstyle="">（GLP-1）</span></span><span leaf="" mpa-font-style="m8zm82j61d6h"><span textstyle="">受体激动剂，能够模拟其作用，减少饥饿感，从而减少饮食、减少热量摄入，因此在减肥方面效果突出</span></span><span leaf="" mpa-font-style="m8zm82j6c5c"><span textstyle="">。</span></span></section><section data-pm-slice="0 0 []"><span leaf="" mpa-font-style="m8zm82j6lwt"><br></span></section><section data-pm-slice="0 0 []"><span leaf="" mpa-font-style="m8zm82j6484"><span textstyle="">除了用于</span></span><span leaf="" mpa-font-style="m8zm82j6i7r"><span textstyle="">治疗</span></span><strong mpa-font-style="m8zm82j61fka"><span leaf=""><span textstyle="">2型糖尿病</span></span></strong><span leaf="" mpa-font-style="m8zm82j61qx2"><span textstyle="">和</span></span><strong mpa-font-style="m8zm82j62bw"><span leaf=""><span textstyle="">肥胖</span></span></strong><span leaf="" mpa-font-style="m8zm82j611r2"><span textstyle="">，司美格鲁肽还被发现能够保护心血管健康、降低癌症风险、帮助戒酒等，此外，还有研究显示，司美格鲁肽能够降低</span></span><strong mpa-font-style="m8zm82j6tkb"><span leaf=""><span textstyle="">慢性肾病</span></span></strong><span leaf="" mpa-font-style="m8zm82j61x43"><span textstyle="">以及</span></span><strong mpa-font-style="m8zm82j6p8h"><span leaf=""><span textstyle="">阿尔茨海默病</span></span></strong><span leaf="" mpa-font-style="m8zm82j61k6d"><span textstyle="">的风险</span></span><span leaf="" mpa-font-style="m8zm82j617os"><span textstyle="">。</span></span></section><section><span leaf="" mpa-font-style="m8zm82j6wbc"><br></span></section><section><span leaf="" mpa-font-style="m8zm82j622p1"><span textstyle="">2025 年 3 月 29 日，在国际顶尖医学期刊《新英格兰医学杂志》</span><span textstyle="">（NEJM）</span><span textstyle="">上发表了题为：</span><span textstyle="">Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes</span><span textstyle=""> 的临床研究论文。</span></span></section><section><span leaf="" mpa-font-style="m8zm82j612ds"><br></span></section><section><span leaf="" mpa-font-style="m8zm82j7x2o"><span textstyle="">这项临床研究显示，</span><span textstyle="">口服版司美格鲁肽</span><span textstyle="">可显著降低患有 2 型糖尿病、动脉粥样硬化性心血管疾病和/或慢性肾病患者的</span><span textstyle="">心血管事件</span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71cl8"><span textstyle="">（例如</span><span textstyle="">心脏病发作</span><span textstyle="">、</span><span textstyle="">中风</span><span textstyle="">）</span><span textstyle="">发生率。</span></span></section><section><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71cl8"><br></span></section><section><span leaf="" mpa-font-style="m8zm82j7yml"><span textstyle="">该研究的领导者、</span></span><span property="familyName" mpa-font-style="m8zm82j785j"><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"section","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">北卡罗来纳大学糖尿病护理中心主任 </span></span><span property="givenName" data-pm-slice="0 0 []"><span leaf=""><span textstyle="">John </span></span></span><span property="familyName"><span leaf=""><span textstyle="">Buse</span><span textstyle=""> 教授表示，</span><span textstyle="">心脏病发作</span><span textstyle="">和</span><span textstyle="">中风</span><span textstyle="">是糖尿病最常见的也是最严重的并发症之一。</span></span><span leaf=""><span textstyle="">司美格鲁肽一直是我们在糖尿病患者中降低心脏病发作和中风风险的主要手段。而能够通过口服方式提供这种高效疗法是一项重大进步。</span></span></span></span></section><section><span property="familyName" mpa-font-style="m8zm82j785j"><span property="familyName"><span leaf=""><br></span></span></span></section><section><span property="familyName" mpa-font-style="m8zm82j785j"><span property="familyName"><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJn8X0ucySVyZaQBPiaMB86genHX6rlqicgaYuVpLaxHf8U8xq1w9rypgkkKzTaAoNvckA8Hicznol3eA/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.534375" data-s="300,640" data-type="png" data-w="1280" type="block" data-backw="562" data-backh="300" data-imgfileid="100292254" src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJn8X0ucySVyZaQBPiaMB86genHX6rlqicgaYuVpLaxHf8U8xq1w9rypgkkKzTaAoNvckA8Hicznol3eA/640?wx_fmt=png&amp;from=appmsg"></span></span></span></section><section><span property="familyName" mpa-font-style="m8zm82j785j"><span property="familyName"><span leaf=""><br></span></span></span></section><p><span leaf="" mpa-font-style="m8zm82j71df6"><span textstyle="">2 型糖尿病是一种进行性疾病，会影响人体控制血糖水平的能力。患有这种疾病的人需要密切监控自己的饮食和运动情况，随着血糖越来越难以控制，他们可能还需要服用药物进行治疗。此外，2 型糖尿病患者患心血管疾病的风险显著增加，因为血糖控制不佳可能导致他们出现高血压、高胆固醇或两者兼而有之。</span></span></p><p><span leaf="" mpa-font-style="m8zm82j71df6"><br></span></p><p><span leaf="" mpa-font-style="m8zm82j7qkd"><span textstyle="">以</span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71lu4"><span textstyle="">司美格鲁肽为代表的 GLP-1 受体激动剂，已被证明在降血糖方面具有很大潜力，但口服版司美格鲁肽是否能实际减少重大心血管事件</span><span textstyle="">（例如心脏病发作、中风）</span><span textstyle="">，仍不清楚。</span></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71lu4"><br></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j714h7"><span textstyle="">在这项名为“司美格鲁肽心血管结局试验”</span><span textstyle="">（简称为：SOUL）</span><span textstyle="">的临床研究中，共招募了 9650 名受试者参与。这些参与者年龄 ≥ 50岁、患有 </span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71s9s"><span textstyle="">2 型糖尿病，糖化血红蛋白水平为 6.5%-10.0%，并且已知患有动脉粥样硬化性心血管疾病和/或慢性肾脏病。</span></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71ta2"><br></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71pqh"><span textstyle="">这些参与者被分为安慰剂组和药物组，以观察服用口服版司美格鲁肽的患者发生重大心脏事件的可能性是否更高或更低。两组均根据当地指南接受了标准的降糖和心血管风险降低治疗。药物组的患者每天服用一次 14 毫克剂量的口服版司美格鲁肽。主要结局指标为重大不良心血管事件</span><span textstyle="">（包括心血管原因导致的死亡、非致命性心肌梗死或非致命性中风）</span><span textstyle="">，采用首次事件发生时间分析法进行评估。</span></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j7xwv"><br></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j7e5t"><span textstyle="">这些参与者的平均随访时间为 47.5±10.9 个月，中位随访时间为 49.5 个月。在药物组的 4825 名参与者中，有 579 人</span><span textstyle="">（12.0%；发生率为3.1例/100人·年）</span><span textstyle="">发生了主要结局事件，而在安慰剂组的 4825 名参与者中，有 668 人</span><span textstyle="">（13.8%；发生率为</span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j7110x"><span textstyle="">3.7例/100人·年）</span><span textstyle="">发生了主要结局事件。</span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j7o4o"><span textstyle="">与安慰剂相比，</span><span textstyle="">口服版司美格鲁肽可使主要心血管事件的风险降低 14%，且不论年龄和性别。</span></span><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j71o05"><span textstyle="">在临床试验中研究的所有类型的主要心脏事件中，非致命性心肌梗死的风险降低幅度最大。</span></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j720ja"><br></span></p><p><span leaf="" mpa-font-style="m8zm82j7125d"><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJn8X0ucySVyZaQBPiaMB86geAekmOGd8JGY05F8CV1wD64hxX0k9573iaiajvMnDaAccuGCuI0sZMRWQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="1.234676007005254" data-s="300,640" data-type="png" data-w="1142" type="block" data-backw="578" data-backh="713" data-imgfileid="100292251" src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJn8X0ucySVyZaQBPiaMB86geAekmOGd8JGY05F8CV1wD64hxX0k9573iaiajvMnDaAccuGCuI0sZMRWQ/640?wx_fmt=png&amp;from=appmsg"></span></p><p><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"p","attributes":{"style":"line-height: 1.75em;"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]' mpa-font-style="m8zm82j7hib"><br></span></p><p><span leaf="" mpa-font-style="m8zm82j71dx6"><span textstyle="">总的来说，这项大规模临床试验表明，在患有 2 型糖尿病以及动脉粥样硬化性心血管疾病和/或慢性肾病的患者中，相比安慰剂，口服版司美格鲁肽能够显著降低主要不良心血管事件的风险，且未增加严重不良事件的发生率。</span></span></p><p><span leaf="" mpa-font-style="m8zm82j711hw"><br></span></p><p><span leaf="" mpa-font-style="m8zm82j7r9l"><span textstyle="">相关阅读</span><span textstyle="">：</span></span></p><p><span leaf="" mpa-font-style="m8zm82j72iy"><br></span></p><section data-pm-slice="0 0 []"><span mpa-font-style="m8zm82j71nue"><span leaf=""><span textstyle="">2024 年 10 月 30 日，哥本哈根大学和诺和诺德公司的研究人员在国际顶尖医学期刊《</span></span><strong><span leaf=""><span textstyle="">新英格兰医学杂志</span></span></strong><span leaf=""><span textstyle="">》</span></span><span><span leaf=""><span textstyle="">（NEJM）</span></span></span><span leaf=""><span textstyle="">发表了题为：</span></span><span><span leaf=""><span textstyle="">Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis</span></span></span><span leaf=""><span textstyle=""> 的研究论文。</span></span></span></section><section><span mpa-font-style="m8zm82j7a1h"><span leaf=""><br></span></span></section><section><span mpa-font-style="m8zm82j7104b"><span leaf=""><span textstyle="">这项临床研究显示，</span></span><strong><span leaf=""><span textstyle="">司美格鲁肽</span></span></strong><span leaf=""><span textstyle="">能够显著减轻体重，并显著减轻肥胖相关的</span></span></span><strong mpa-font-style="m8zm82j71o4p"><span><span leaf=""><span textstyle="">膝关节炎</span></span></span></strong><span mpa-font-style="m8zm82j7262"><span leaf=""><span textstyle="">引起的疼痛</span></span><span><span leaf=""><span textstyle="">（止痛效果与阿片类药物相当）</span></span></span><span><span leaf=""><span textstyle="">，</span></span></span><span leaf=""><span textstyle="">并提高他们参与运动的能力。这也是</span></span></span><span mpa-font-style="m8zm82j724ae"><span leaf=""><span textstyle="">第一次证实 GLP-1 受体激动剂类新型减肥药物可以治疗关节炎。</span></span></span></section><section><span mpa-font-style="m8zm82j71z5y"><span leaf=""><br></span></span></section><section><span mpa-font-style="m8zm82j71avh"><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlBnkryDAJVsLJhiaGBEwyIB8KWsw7niax15yG0e0iartiaHVhI9sr27RrMq4zouDES0nFiaoNxGgb8Tzw/640?wx_fmt=png&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" alt="图片" data-ratio="0.42777777777777776" data-s="300,640" data-type="png" data-w="1080" data-backw="562" data-backh="240" data-imgfileid="100273611" src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlBnkryDAJVsLJhiaGBEwyIB8KWsw7niax15yG0e0iartiaHVhI9sr27RrMq4zouDES0nFiaoNxGgb8Tzw/640?wx_fmt=png&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></span></span></section><p><span leaf="" mpa-font-style="m8zm82j7kfm"><br></span></p><p><span data-pm-slice="0 0 []"><span leaf="">研究团队表示，</span></span><span><span leaf="">司美格鲁肽治疗带来的这种改善可能部分源于体重减轻导致的膝盖负荷减少。但同时司美格鲁肽也具有抗炎作用，这可能有助于解释患者的疼痛得到了显著缓解。</span></span></p><section><span leaf="" mpa-font-style="m8zm82j71txx"><br></span></section><section><span leaf="" mpa-font-style="m8zm82j71txx"><span textstyle="">论文链接</span><span textstyle="">：</span></span></section><section><span leaf="" mpa-font-style="m8zm82j7yvt"><span textstyle="">https://www.nejm.org/doi/10.1056/NEJMoa2501006</span></span></section><section><span data-pm-slice="0 0 []"><span leaf="">https://www.nejm.org/doi/10.1056/NEJMoa2403664</span></span></section><section><span mpa-font-style="m8zm82j8zct"><font><section><span data-mpa-action-id="m8slugegoe8" data-pm-slice='2 12 ["para",{"tagName":"section","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"mpa-font-style":"m8wjiebibpp","style":"font-family: \"mp-quote\", -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"font","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"},"para",{"tagName":"section","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span leaf=""><br></span><p><span><a href="https://mp.weixin.qq.com/s?__biz=MzIzOTM4NDcyNw==&amp;mid=2247537249&amp;idx=3&amp;sn=513e839f9d48c7c41a5184ce45b71d32&amp;scene=21#wechat_redirect" imgurl="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlRNpTicHD8iagW8jsMl4BMZerHV0TrJXoichms5umCyLOWnialsMhTfdPcm0xEHDj3iaF6wVnNhSeq5oQ/640?wx_fmt=png&amp;from=appmsg" linktype="image" tab="innerlink" data-itemshowtype="0" target="_blank" data-linktype="1"><span><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlRNpTicHD8iagW8jsMl4BMZerHV0TrJXoichms5umCyLOWnialsMhTfdPcm0xEHDj3iaF6wVnNhSeq5oQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.4255555555555556" data-s="300,640" data-type="png" data-w="900" type="block" data-backw="562" data-backh="239" data-imgfileid="100291912" src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJlRNpTicHD8iagW8jsMl4BMZerHV0TrJXoichms5umCyLOWnialsMhTfdPcm0xEHDj3iaF6wVnNhSeq5oQ/640?wx_fmt=png&amp;from=appmsg"></span></a></span></p><section><font><span><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJmIkPXwe5UueZ9YUl77BR7P4EfdZWlH3gmd0PnbzGGKzOKk45JsvQaEUkGf5hcIJ4Fyq6nHd3YBpw/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="0.42592592592592593" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="239" data-imgfileid="100285709" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJmIkPXwe5UueZ9YUl77BR7P4EfdZWlH3gmd0PnbzGGKzOKk45JsvQaEUkGf5hcIJ4Fyq6nHd3YBpw/640?wx_fmt=jpeg&amp;from=appmsg"></span></span></font></section><section><font><span><span><span leaf=""><a href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247649820&amp;idx=1&amp;sn=1c6ff4767bbb6040f157864685d8a987&amp;chksm=fbf87ec9cc8ff7dfc75a38ee561a5ab1629ce16bcd398f8f3f6b2803e27e41d8b5b7e8a00d2a&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" data-itemshowtype="0" target="_blank" linktype="text" data-linktype="2"><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJnrjgR9xicl0z6CqtEictIb22ibOib4ZaScu8iaVzglysI6FEiaO8Ibdxmiaq3erkM7zGN5pIiavvhDK3ibic8w/640?wx_fmt=jpeg" data-ratio="0.42314814814814816" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="238" data-imgfileid="100285711" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJnrjgR9xicl0z6CqtEictIb22ibOib4ZaScu8iaVzglysI6FEiaO8Ibdxmiaq3erkM7zGN5pIiavvhDK3ibic8w/640?wx_fmt=jpeg"></a></span></span></span></font></section><section data-role="outer" label="Powered by 135editor.com"><section><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t" nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/73icnXvmN7wOI0rvtgpcAvoymzwXc4GsnicX7nxUa21NoWg2J48JaZ95yswdzic3MZ3Hagz97n5zdXiaMtm7ic36oTA/640?wx_fmt=png" data-ratio="0.2573099415204678" data-type="png" data-w="342" data-fileid="100088548" data-imgfileid="100285708" src="https://mmbiz.qpic.cn/mmbiz_png/73icnXvmN7wOI0rvtgpcAvoymzwXc4GsnicX7nxUa21NoWg2J48JaZ95yswdzic3MZ3Hagz97n5zdXiaMtm7ic36oTA/640?wx_fmt=png"></section></section></section><section><font><span><span><span leaf=""><a href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247644260&amp;idx=1&amp;sn=b54c9e45e37630f844b7548f1a46459b&amp;chksm=fbf840b1cc8fc9a73867c5e75e9e69acedcbb2ad91df9e8d3cdd2ae7a030ed9d401cb1d268e6&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" data-itemshowtype="0" target="_blank" linktype="text" data-linktype="2"><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10vnQicwUlPf2ialpAYdmzYrlVpcicLWjT7Hib8ajEo8Bbz1t52iaM6zZkubQ/640?wx_fmt=jpeg" data-ratio="0.08796296296296297" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="49" data-imgfileid="100285710" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10vnQicwUlPf2ialpAYdmzYrlVpcicLWjT7Hib8ajEo8Bbz1t52iaM6zZkubQ/640?wx_fmt=jpeg"></a></span></span></span></font></section><section><font><span><span><span leaf=""><a href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247644250&amp;idx=1&amp;sn=db6d18e36b3153a968d7a9c11d1a67a9&amp;chksm=fbf8408fcc8fc99952e603ba24d0a10256855a593aeaf9bd400d18e4c0f0f0a06e49fdd023f8&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" data-itemshowtype="0" target="_blank" linktype="text" data-linktype="2"><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10gJJRKwUNkKhUqcj55lBzaMXv2Y2iaExAqFBf4CXibk9TP1LLzzgqZCuQ/640?wx_fmt=jpeg" data-ratio="0.08796296296296297" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="49" data-imgfileid="100285707" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10gJJRKwUNkKhUqcj55lBzaMXv2Y2iaExAqFBf4CXibk9TP1LLzzgqZCuQ/640?wx_fmt=jpeg"></a></span></span></span></font></section><section><font><span><span><span leaf=""><a href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247642379&amp;idx=1&amp;sn=d7bff2587965494403b92ebbd921fab9&amp;chksm=fbf859decc8fd0c8e539552911861ca594baf3e53c2b84a43542eb904e70e52918ecf997f4e0&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" data-itemshowtype="0" target="_blank" linktype="text" data-linktype="2"><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10iaZ62PXgrHr1RhZhPcddeFsKn5m2p5LElTzZTLnVnSK49vbJmm7cxPw/640?wx_fmt=jpeg" data-ratio="0.08796296296296297" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="49" data-imgfileid="100285712" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10iaZ62PXgrHr1RhZhPcddeFsKn5m2p5LElTzZTLnVnSK49vbJmm7cxPw/640?wx_fmt=jpeg"></a></span></span></span></font></section><section><font><span><span><span leaf=""><a href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247644257&amp;idx=1&amp;sn=b3b7dceb825ef6b685e30d618a3b586e&amp;chksm=fbf840b4cc8fc9a2fddc9c5e1ac659f198df1ff30aa4f66f05d57d2bc775dc45a7a08aabecaf&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" data-itemshowtype="0" target="_blank" linktype="text" data-linktype="2"><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10o3qRJVpkVYVkAvT13XS2DUTkibXVVWXuEcg0ic7gO2iaaYia11J5j2dKYg/640?wx_fmt=jpeg" data-ratio="0.08796296296296297" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="49" data-imgfileid="100285713" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10o3qRJVpkVYVkAvT13XS2DUTkibXVVWXuEcg0ic7gO2iaaYia11J5j2dKYg/640?wx_fmt=jpeg"></a></span></span></span></font></section><section><font><span><span leaf=""><span textstyle="">设置</span></span><strong><span leaf=""><span textstyle="">星标</span></span></strong><span leaf=""><span textstyle="">，不错过精彩推文</span></span></span></font></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJkrZeMyHWr8nm80OyVfDQBpsT8rnQMxic0BEicTN0D4xTnoicumrbrBjUCh5uFtJEib7CLIeX8yxlUxcg/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-ratio="0.21203703703703702" data-s="300,640" data-type="jpeg" data-w="1080" data-cropselx1="0" data-cropselx2="520" data-cropsely1="0" data-cropsely2="110" data-backw="562" data-backh="119" data-imgfileid="100285714" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJkrZeMyHWr8nm80OyVfDQBpsT8rnQMxic0BEicTN0D4xTnoicumrbrBjUCh5uFtJEib7CLIeX8yxlUxcg/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJkmevYiaqUYPrQo4e6MgLEQP9TGLE88v8QWKaic8ricVmCA52SkIX35mtMzAiaQNibKmDhYNeK4uMzGRicQ/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-ratio="0.225" data-s="300,640" data-type="jpeg" data-w="1080" data-backw="562" data-backh="126" data-imgfileid="100285715" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJkmevYiaqUYPrQo4e6MgLEQP9TGLE88v8QWKaic8ricVmCA52SkIX35mtMzAiaQNibKmDhYNeK4uMzGRicQ/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section><font><span><strong><span leaf=""><span textstyle="">开放转载</span></span></strong></span></font></section><section><font><span><span leaf=""><span textstyle="">欢迎转发到朋友圈和微信群</span></span></span></font></section><section powered-by="xiumi.us"><section><section><section data-id="1849" data-tools="新媒体排版" data-style-type="2"><section><section><font><span><strong><span><span leaf=""><span textstyle=""> 微信加群 </span></span></span></strong><strong></strong></span></font></section><section><section><font><span><span><span leaf=""><span textstyle="">为促进前沿研究的传播和交流，我们组建了多个</span></span><strong><span leaf=""><span textstyle="">专业交流群</span></span></strong><span leaf=""><span textstyle="">，长按下方二维码，即可添加小编微信进群，由于申请人数较多，添加微信时请备注：</span></span><strong><span leaf=""><span textstyle="">学校</span></span></strong><span leaf=""><span textstyle="">/</span></span><strong><span leaf=""><span textstyle="">专业</span></span></strong><span leaf=""><span textstyle="">/</span></span><strong><span leaf=""><span textstyle="">姓名</span></span></strong><span leaf=""><span textstyle="">，如果是</span></span></span><span><strong><span leaf=""><span textstyle="">PI</span></span></strong></span><span><span leaf=""><span textstyle="">/</span></span></span><strong><span><span leaf=""><span textstyle="">教授</span></span></span></strong><span><span leaf=""><span textstyle="">，还请注明。</span></span></span></span></font></section><section><font><span leaf=""><br></span></font></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJlXd8xpTjuxrR42rUB5g9TNU1N6Qj1tyRwfGJIKKDn85DRJk7kfyLfYP5XsvVVPqa9sE8pcfaevbQ/640?wx_fmt=jpeg" data-ratio="1.3631578947368421" data-s="300,640" data-type="jpeg" data-w="950" data-cropselx1="0" data-cropselx2="163" data-cropsely1="0" data-cropsely2="163" data-fileid="100088553" data-imgfileid="100285716" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJlXd8xpTjuxrR42rUB5g9TNU1N6Qj1tyRwfGJIKKDn85DRJk7kfyLfYP5XsvVVPqa9sE8pcfaevbQ/640?wx_fmt=jpeg"></section></section></section></section><p><font><span><span><strong><strong><span leaf=""><span textstyle="">点</span></span></strong></strong></span><span><strong><strong><span leaf=""><span textstyle="">在看</span></span></strong></strong></span><span><strong><strong><span leaf=""><span textstyle="">，传递你的品味</span></span></strong></strong></span></span></font></p></section></section></section></section></span></section></font></span></section><p><mp-style-type data-value="10000"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/qzSG93TzzNzprKGocFMECg",target="_blank" rel="noopener noreferrer">原文链接</a>
